Santhera Pharmaceuticals Holding AG (SANN.SW)
CHF 9.86
(2.49%)
CHF 9.86
(2.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 103.41 Million | 7.47 Million | -1.59 Million | 15 Million | 75.37 Million | 31.65 Million |
| Cost of Revenue | 3.87 Million | 3.59 Million | 3.76 Million | 10.43 Million | 5.45 Million | 4.7 Million |
| Gross Profit | 99.54 Million | 3.88 Million | -5.36 Million | 4.57 Million | 69.92 Million | 26.95 Million |
| Operating Expenses | 31.33 Million | 55.85 Million | 51.52 Million | 57.65 Million | 80.36 Million | 78.37 Million |
| Selling, General and Administrative Expenses | 30.96 Million | 25.42 Million | 22.05 Million | 23.91 Million | 39.28 Million | 40.24 Million |
| Research and Development Expenses | 18.67 Million | 30.53 Million | 29.71 Million | 34.22 Million | 41.24 Million | 38.24 Million |
| Other Expenses | -18.3 Million | -101 Thousand | -246 Thousand | -489 Thousand | -156 Thousand | -114 Thousand |
| Cost and Expenses | 34.57 Million | 59.44 Million | 55.29 Million | 68.08 Million | 85.81 Million | 83.07 Million |
| Operating Income | 68.84 Million | -51.97 Million | -56.88 Million | -53.07 Million | -10.44 Million | -51.42 Million |
| Interest Expense | 21.31 Million | 20.18 Million | 16.42 Million | 6.89 Million | 6.08 Million | 4.5 Million |
| Income Tax Expense | 38 Thousand | 460 Thousand | 809 Thousand | 203 Thousand | 579 Thousand | 322 Thousand |
| Earnings before Tax | 54.82 Million | -70.61 Million | -54.71 Million | -67.45 Million | -18.39 Million | -53.86 Million |
| Net Income | 54.78 Million | -71.07 Million | -55.52 Million | -67.65 Million | -18.97 Million | -54.18 Million |
| Earnings Per Share Basic | 5.18 | -11.67 | -16.25 | -50.81 | -17.26 | -78.63 |
| Earnings Per Share Diluted | 5.01 | -11.67 | -16.25 | -50.81 | -17.26 | -78.63 |
| Weighted Average Shares Outstanding | 10.57 Million | 6.09 Million | 3.41 Million | 1.33 Million | 1.09 Million | 689.16 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 10.92 Million | 6.09 Million | 3.41 Million | 1.33 Million | 1.09 Million | 689.16 Thousand |
| Gross Margin | 0.96 | 0.52 | 3.36 | 0.30 | 0.93 | 0.85 |
| EBIT Margin | 0.77 | -5.69 | 27.10 | -3.59 | -0.09 | -1.52 |
| Profit Margin | 0.53 | -9.51 | 34.81 | -4.51 | -0.25 | -1.71 |
| EBITDA | 79.17 Million | -46.77 Million | -34.57 Million | -53.42 Million | -7.54 Million | -45.62 Million |
| Earnings Before Tax Margin | 0.67 | -6.96 | 35.67 | -3.54 | -0.14 | -1.62 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.05 Million | 7.05 Million | 99.43 Million | 103.37 Million | 49.71 Million | 3.93 Million |
| Cost of Revenue | 2.6 Million | 2.6 Million | 1.63 Million | 3.87 Million | 653.5 Thousand | 2.23 Million |
| Gross Profit | 4.44 Million | 4.44 Million | 97.8 Million | 99.5 Million | 49.06 Million | 1.7 Million |
| Operating Expenses | 13.32 Million | 13.32 Million | 26.95 Million | 49 Million | 2.73 Million | 22.05 Million |
| Selling, General and Administrative Expenses | 6.46 Million | 6.46 Million | 18.02 Million | - | 9.17 Million | 12.3 Million |
| Research and Development Expenses | 6.88 Million | 6.88 Million | 8.92 Million | - | 4.46 Million | 9.74 Million |
| Other Expenses | -28 Thousand | -28 Thousand | -9.13 Million | - | - | - |
| Cost and Expenses | 15.92 Million | 15.92 Million | 28.59 Million | 52.87 Million | 3.38 Million | 24.28 Million |
| Operating Income | -8.87 Million | -8.87 Million | 70.84 Million | 50.5 Million | 35.71 Million | -20.34 Million |
| Interest Expense | - | - | 25.35 Million | 33.37 Million | - | 8.01 Million |
| Income Tax Expense | 87 Thousand | 87 Thousand | 123 Thousand | 39 Thousand | 61.5 Thousand | -84 Thousand |
| Earnings before Tax | -7.54 Million | -7.54 Million | 78.24 Million | 54.82 Million | 39.12 Million | -23.42 Million |
| Net Income | -7.63 Million | -7.63 Million | 78.11 Million | 54.78 Million | 39.05 Million | -23.33 Million |
| Earnings Per Share Basic | -0.67 | -0.67 | 7.00 | - | 3.50 | -2.09 |
| Earnings Per Share Diluted | -0.67 | -0.67 | 7.00 | - | 3.50 | -2.09 |
| Weighted Average Shares Outstanding | 11.33 Million | 11.33 Million | 11.15 Million | 11.15 Million | 11.15 Million | 11.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.33 Million | 11.33 Million | 11.15 Million | 11.15 Million | 11.15 Million | 11.15 Million |
| Gross Margin | 0.63 | 0.63 | 0.98 | 0.96 | 0.99 | 0.43 |
| EBIT Margin | -1.06 | -1.06 | 0.72 | - | 0.73 | -4.70 |
| Profit Margin | -1.08 | -1.08 | 0.79 | 0.53 | 0.79 | -5.92 |
| EBITDA | -7.48 Million | -7.48 Million | 72.06 Million | - | 36.32 Million | -18.52 Million |
| Earnings Before Tax Margin | -1.26 | -1.26 | 0.71 | 0.49 | 0.72 | -5.17 |
RVMDW
ERT
VALIANTORG
AZ
008260
SVTNF